Farmaceutica REMEDIA S.A. (BVB:RMAH)
0.7120
+0.0060 (0.85%)
At close: Oct 8, 2025
Farmaceutica REMEDIA Revenue
Farmaceutica REMEDIA had revenue of 177.02M RON in the quarter ending June 30, 2025, a decrease of -2.08%. This brings the company's revenue in the last twelve months to 756.45M, up 13.90% year-over-year. In the year 2024, Farmaceutica REMEDIA had annual revenue of 743.79M with 25.35% growth.
Revenue (ttm)
756.45M
Revenue Growth
+13.90%
P/S Ratio
0.09
Revenue / Employee
3.29M
Employees
230
Market Cap
67.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 743.79M | 150.43M | 25.35% |
Dec 31, 2023 | 593.36M | 57.51M | 10.73% |
Dec 31, 2022 | 535.85M | 58.75M | 12.31% |
Dec 31, 2021 | 477.10M | 35.62M | 8.07% |
Dec 31, 2020 | 441.48M | -4.93M | -1.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OMV Petrom | 33.96B |
S.P.E.E.H. Hidroelectrica | 8.35B |
SNGN Romgaz | 8.28B |
Banca Transilvania | 9.93B |
BRD - Groupe Société Générale | 4.00B |
S.N. Nuclearelectrica | 5.48B |
S.N.T.G.N. Transgaz | 4.67B |
Digi Communications | 12.81B |